Hints and tips:
...For example, AbbVie in 2014 paid $1.6bn to Shire after its tax inversion deal collapsed, roughly 3 per cent of the $53bn equity purchase price....
...How to balance tradition with modernity will be a hot topic on Monday, when the Lord Mayor of London will mark pubs reopening by delivering a barrel of beer by shire horse to the Old Dr Butler’s Head (established...
...Takeda has estimated it will have $48bn in net debt after the deal closes, including $13.7bn of Shire’s debt and acquisition debt of $29.8bn....
...The payday would mark the second time Mr Hantson has cashed in by selling a pharma company he runs, following Shire’s $32bn takeover of US drugmaker Baxalta in 2016....
...Xiidra, however, had been part of the Shire portfolio....
...John McDonnell, the UK shadow chancellor, looks like a grandfather from the shires and speaks in tones of gentle reasonableness....
...The acquisition added Shire’s lucrative rare diseases portfolio to Takeda’s pipeline, which lacked big late-development experimental drugs....
...Last year Randgold Resources, Shire, Sky and Worldpay were all bought and left the index....
...In a clear nod to the looming negotiations on fishing rights, one cabinet minister noted: “We don’t just want to focus on UK plc but also the impact on communities.”...
...Advisors to institutional investors have given the all clear for what would be corporate Japan’s largest ever overseas takeover, the £46bn ($59bn) purchase of the UK’s Shire by Takeda Pharmaceutical....
...EU Competition Commissioner Margrethe Vestager said: “We can today approve the merger between Shire and Takeda, but only subject to the divestment of the product that Shire is developing to treat the (inflammatory...
...“Shire’s assets will run out in 10 years,” Mr Sakai said. “Takeda basically bought five years’ worth of time through this deal....
...It will also increase its exposure in the US, the world’s largest pharmaceutical market, which will account for roughly half of its revenue after integrating Shire....
...And, on Monday, it was inflaming passions from the City to the shires. Ocado’s shares leapt 4 per cent in early trading, with Marks’ up 2 per cent....
...Unhappy shareholders are right to resist the purchase of Shire. Not least, it will help establish what a censure vote looks like....
...Mr Weber has also said Takeda evaluated the pressure on Shire’s haemophilia franchise from a new rival drug made by Swiss pharma group Roche before arriving at the £46bn valuation for Shire....
...“Longer term, will Takeda need to continue finding the second and third Shire?”...
...In Japan, dissident Takeda shareholders wanting to block the takeover of Shire raised fears over the latter’s haemophilia franchise, responsible for a quarter of its sales....
...In June, Shire received US regulatory approval from the US Food and Drug Administration for a new state of the art plasma manufacturing facility in the state of Georgia that Shire said would boost its internal...
...Like the Kurosawa classic 1950 film Rashomon, Takeda Pharmaceutical’s £46bn takeover bid for Shire is a drama whose central incident can be described in different ways....
...Takeda Pharmaceutical has received US regulatory approval for its £46bn takeover of Irish drugmaker Shire, clearing a “significant” hurdle to completing Japan’s largest-ever outbound acquisition....
...In early July, the company received US regulatory approval for the Shire deal but it is still undergoing antitrust review in other major markets such as Japan, Europe and China....
...Many retail investors are also dismayed that Takeda’s stock has fallen 18 per cent since the company revealed its interest in Shire in March....
...However, this morning, SLA said it had “informed Lloyds Banking Group that it does not agree that, following the merger of Aberdeen Asset Management PLC and Standard Life plc, SLA was in material competition...
...On the Takeda bid he said Shire was “engaged in discussion with Takeda on the terms of a possible offer” on which both parties were able to undertake due diligence....
International Edition